Drawing for TRIALSPARK SCOUT

USPTO serial 87600062

TRIALSPARK SCOUT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PARK, JENNY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TRIALSPARK SCOUT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allison Strickland Ricketts

Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd St., 17th FlNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Software for recruiting patients for clinical trials and related clinical research, namely, software for screening, selecting, and managing candidates for clinical trials and related clinical research; Software for management of clinical trials and related clinical research; Software for the design and administration of clinical research studiesACTIVE—
035Recruitment of patients for clinical trials and related clinical research; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials; Advertising, promotion, and marketing services in the nature of using social and digital media technology to find patients for medical providers and to connect patients to clinical studies; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approvalACTIVE—
042Providing temporary use of on-line non-downloadable software for management of clinical trials and related clinical research; Providing temporary use of a web-based software application for tracking medical patients, patient records, patient biometrics, patient surgeries and outcomes of medical procedures for patients; Software as a service (SAAS) services featuring software to recruit patients for clinical trials and related clinical research, namely, software for screening, selecting, and managing candidates for medical and scientific research and for clinical trials and related clinical research; Software as a service (SAAS) services featuring software for enabling users to view, manage and report on patient-reported data in pharmaceutical industry clinical trials; Providing a website featuring information in the field of clinical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 7, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 7, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 16, 2022EX5GSOU EXTENSION 5 GRANTED—
Mar 11, 2022EXT5SOU EXTENSION 5 FILED—
Mar 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 22, 2021EX4GSOU EXTENSION 4 GRANTED—
Oct 20, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 6, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Oct 6, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 6, 2021PETGPETITION TO REVIVE-GRANTED—
Oct 6, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Oct 1, 2021EXT4SOU EXTENSION 4 FILED—
Mar 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2021EX3GSOU EXTENSION 3 GRANTED—
Mar 25, 2021EXT3SOU EXTENSION 3 FILED—
Mar 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 30, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 28, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 28, 2020EXT2SOU EXTENSION 2 FILED—
Sep 28, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 30, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 30, 2020EXT1SOU EXTENSION 1 FILED—
Mar 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 16, 2019TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 16, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Aug 16, 2019OP.DOPPOSITION DISMISSED NO. 999999—
Jan 28, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 29, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 31, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 15, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017DOCKASSIGNED TO EXAMINER—
Sep 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance